Background and importance The emergence of new technologies has allowed great
advances in the way we communicate. The hospital pharmacy can take advantage of these …

Background Atypical haemolytic uraemic syndrome (aHUS) is a severe life threatening
disease with progression to end stage renal disease. Eculizumab, a humanised anti-C5 …

Background Hazardous drugs (MPs) are defined as the drugs that cause carcinogenicity,
teratogenicity, reproductive toxicity, low-dose organ toxicity, genotoxicity, and new drugs …

Background Apremilast is an orally-active small molecule which inhibits phosphodiesterase-
4 (PDE4). Clinical trials have demonstrated its efficacy and safety in psoriatic arthritis (PsA) …

Background Up until 2014, basiliximab was used in our hospital as an off-label prescription
for hepatic transplantation in patients for whom starting tacrolimus had to be delayed …

Background Documentation of interventions is vital to a patient's continuity of care and
demonstrates the value of clinical pharmacy. Purpose The aim of this study was to describe …

Las fracturas de cadera del anciano suponen un grave problema de salud, con una
mortalidad elevada, una importante pérdida de salud, un aumento de la dependencia y un …

Hola Chat GPT, ¿Qué hace una inteligencia artificial como tú en una farmacia hospitalaria
como ésta? SciELO - Scientific Electronic Library Online vol.33 número2 Futuro del …

Internet y las tecnologías digitales han emergido exponencialmente para transformar
prácticamente todos los sectores productivos de la sociedad, provocando la llamada “cuarta …